Easy To Use Patents Search & Patent Lawyer Directory

At Patents you can conduct a Patent Search, File a Patent Application, find a Patent Attorney, or search available technology through our Patent Exchange. Patents are available using simple keyword or date criteria. If you are looking to hire a patent attorney, you've come to the right place. Protect your idea and hire a patent lawyer.

Searching:





Search by keyword, patent number, inventor, assignee, city or state:




Patent # Description
2017/0151219 ANTIPERSPIRANT AGENT
The present invention provides an antiperspirant which can effectively and safely control perspiration. The antiperspirant in accordance with an aspect of the...
2017/0151218 PHARMACEUTICAL COMBINATIONS FOR TREATING CANCER
The present invention is directed to a combination comprising a proteasome inhibitor and a compound of formula I or a pharmaceutically acceptable salt...
2017/0151217 STABILIZED OXYMETAZOLINE FORMULATIONS AND THEIR USES
The present invention provides stabilized cream formulations of oxymetazoline and uses thereof. The present invention also provides a method of treating facial...
2017/0151216 TREATMENT OF AUTISTIC SPECTRUM DISORDER
A kit, optionally for treating a patient having ASD, is disclosed. The kit includes at least one first package and at least one second package. The first...
2017/0151215 USE OF ROTIGOTINE FOR TREATING THE RESTLESS LEG SYNDROME
This invention relates to the use of rotigotine for the effective treatment of Restless Leg Syndrome (RLS) as well as to a rotigotine-containing...
2017/0151214 METHOD FOR THE TREATMENT OF DRAVET SYNDROME
A method of treating and/or preventing Dravet Syndrome in a patient such as a patient previously diagnosed with Dravet Syndrome, by administering an effective...
2017/0151213 METHOD FOR THE TREATMENT OF DRAVET SYNDROME
A method of treating and/or preventing Dravet Syndrome in a patient such as a patient previously diagnosed with Dravet Syndrome, by administering an effective...
2017/0151212 PRENYLATED ISOFLAVONES FOR TREATMENT OF SUBJECTS WITH MULTIDRUG-RESISTANT CANCER
Prenylated isoflavones are suitable to specifically inhibit P-glycoprotein in multidrug-resistant cancer cells leading to an accumulation of cytotoxic...
2017/0151211 Desethylamiodarone for use in cancer treatment
The invention relates to a compound selected from the group consisting of desethylamiodarone and pharmaceutically acceptable salts, hydrates and solvates...
2017/0151210 NITROXYL DONORS WITH IMPROVED THERAPEUTIC INDEX
The disclosed subject matter provides N-substituted hydroxylamine derivative compounds, pharmaceutical compositions and kits comprising such compounds, and...
2017/0151209 METHODS FOR TREATING BIPOLAR DISORDER
The invention is directed to a method of treating bipolar disorder in a subject, comprising administering a therapeutically effective amount of a carbamate...
2017/0151208 METHODS FOR INHIBITING CONVERSION OF CHOLINE TO TRIMETHYLAMINE (TMA)
The invention provides one or more methods of inhibiting the conversion of choline to trimethylamine (TMA) and lowering TMAO in an individual comprising...
2017/0151207 Ester and Cholinesterase Inhibitor in Long-Acting Nerve Block
Pharmaceutical compositions comprising an ester anesthetic and a cholinesterase inhibitor have been found to exhibit surprising and beneficial results in...
2017/0151206 COMPOSITION FOR PREVENTING THE OCCURRENCE OF CARDIOVASCULAR EVENT IN MULTIPLE RISK PATIENT
Disclosed is a composition which is useful for preventing the occurrence of a cardiovascular event, particularly a composition which is expected to show a...
2017/0151205 COMPOSITIONS AND METHODS OF USE OF PHORBOL ESTERS
Methods and compositions containing a phorbol ester or a derivative of a phorbol ester are provided for the treatment of cytopathic diseases. Cytopathic...
2017/0151204 USE OF LEUKOTRIENE B4 IN COMBINATION WITH A TOLL-LIKE RECEPTOR LIGAND, A RIG-I-LIKE RECEPTOR LIGAND, OR A...
The present invention relates to the use of leukotriene B.sub.4 to enhance the response of Toll-like receptor (TLR), RIG-I-like receptor (RLR), and NOD-like...
2017/0151203 INFANT NUTRITION FOR IMPROVING FATTY ACID COMPOSITION OF BRAIN MEMBRANES
The present invention relates to infant nutrition, in particular to infant nutrition comprising special lipid globules for improvement of the fatty acid...
2017/0151202 METHODS OF REDUCING OR PREVENTING OXIDATION OF SMALL DENSE LDL OR MEMBRANE POLYUNSATURATED FATTY ACIDS
In various embodiments, the present invention provides methods of treating and/or preventing cardiovascular-related disease and, in particular, a method of...
2017/0151201 COMPOSITIONS AND METHODS FOR TREATING FIBROMYALGIA
Embodiments of the invention generally relate to supplements for treating fibromyalgia and symptoms associated with fibromyalgia.
2017/0151200 PROPHYLACTIC OR THERAPEUTIC AGENT FOR IDIOPATHIC INFLAMMATORY MYOPATHIES
Administration of isoleucine, leucine and valine is effective for the prophylaxis and/or therapy of idiopathic inflammatory myopathy or idiopathic inflammatory...
2017/0151199 PHARMACEUTICAL COMPOSITIONS AND THE TREATMENT OF OVERACTIVE BLADDER
The present invention relates to methods of treating overactive bladder and the symptoms associated therewith, for example, urinary urgency, frequency of...
2017/0151198 ORGAN PROTECTION SOLUTIONS AND METHOD OF USE
An organ protectant solution which is intravenously administered includes at least one oncotic agent and optionally a high concentration of cell-impermeant...
2017/0151197 LAUFLUMIDE AND THE ENANTIOMERS THEREOF, METHOD FOR PREPARING SAME AND THERAPEUTIC USES THEREOF
The invention relates to the molecule having formula (I), as well as the enantiomers thereof, and to the use of same in the treatment of ADHD, narcolepsy or...
2017/0151196 NOVEL THERAPEUTIC USES OF BENZYLIDENEGUANIDINE DERIVATIVES FOR THE TREATMENT OF PROTEOPATHIES
The present invention relates to novel uses of a compound of formula (I), or a tautomer and/or a pharmaceutically acceptable salt thereof, in treating a...
2017/0151195 Compositions Comprising Sphingosine 1 Phosphate (S1P) Receptor Modulators
The present invention relates to stable compositions comprising a sphingosine 1 phosphate (S1P) receptor modulator, suitable for use as a dosage form. The S1P...
2017/0151194 METHOD FOR THE TREATMENT OF DRAVET SYNDROME
A method of treating and/or preventing Dravet Syndrome in a patient such as a patient previously diagnosed with Dravet Syndrome, by administering an effective...
2017/0151193 PHARMACEUTICAL SOLUTION COMPRISING DOPAMINE FOR USE IN TREATING PARKINSON'S DISEASE
The present invention is directed to pharmaceutical solution comprising at least dopamine for use in treating Parkinson's disease, wherein said pharmaceutical...
2017/0151192 METHODS, COMPOSITIONS AND DEVICES FOR TREATMENT OF MOTOR AND DEPRESSION SYMPTOMS ASSOCIATED WITH PARKINSON'S...
Disclosed is a method of treating Parkinson's disease and/or depression, and motor symptoms, non motor symptoms and depression symptoms associated with...
2017/0151191 INTRANASAL ADMINISTRATION OF KETAMINE TO TREAT DEPRESSION
Methods and compositions for the treatment of treatment-resistant depression are described. More specifically, the invention demonstrates that intranasal...
2017/0151190 AMANTADINE COMPOSITIONS AND METHODS OF USE
Methods of nighttime administration of amantadine to reduce sleep disturbances in patient undergoing treatment with amantadine are described, as well as...
2017/0151189 COMPOSITION AND METHOD FOR TREATING NEUROLOGICAL DISEASE
Disclosed are compositions comprising amantadine, or a pharmaceutically acceptable salt thereof, and one or more excipients, wherein at least one of the...
2017/0151188 COMPOSITION AND METHOD FOR TREATING NEUROLOGICAL DISEASE
Disclosed are compositions comprising amantadine, or a pharmaceutically acceptable salt thereof, and one or more excipients, wherein at least one of the...
2017/0151187 AMANTADINE COMPOSITIONS AND METHODS OF USE
Methods of nighttime administration of amantadine to reduce sleep disturbances in patient undergoing treatment with amantadine are described, as well as...
2017/0151186 AMANTADINE COMPOSITIONS AND METHODS OF USE
Methods of nighttime administration of amantadine to reduce sleep disturbances in patient undergoing treatment with amantadine are described, as well as...
2017/0151185 AMANTADINE COMPOSITIONS AND METHODS OF USE
Methods of nighttime administration of amantadine to reduce sleep disturbances in patient undergoing treatment with amantadine are described, as well as...
2017/0151184 AMANTADINE COMPOSITIONS AND METHODS OF USE
Methods of nighttime administration of amantadine to reduce sleep disturbances in patient undergoing treatment with amantadine are described, as well as...
2017/0151183 AMANTADINE COMPOSITIONS AND METHODS OF USE
Methods of nighttime administration of amantadine to reduce sleep disturbances in patient undergoing treatment with amantadine are described, as well as...
2017/0151182 TREATMENT OF SCHIZOPHRENIA USING BETA-CARYOPHYLLENE AND CB2 RECEPTOR AGONISTS
Disclosed are compositions comprising beta-caryophyllene (BCP) for use in the treatment of schizophrenia, methods of making such compositions and methods of...
2017/0151181 METHODS OF TREATING CANCERS WITH THERAPEUTIC NANOPARTICLES
The present disclosure relates in part to methods of treating cancers having a mutation in a Ras gene in a patient in need thereof, comprising administering to...
2017/0151180 BUPRENORPHINE NANOPARTICLE COMPOSITION AND METHODS THEREOF
Stable nanoparticle compositions comprising buprenorphine and at least one biodegradable polymer. The disclosure also provides methods of controlling pain in...
2017/0151179 Low Dose Topiramate/Phentermine Composition and Methods of Use Thereof
A method for effecting weight loss by administering a combination of topiramate and phentermine is provided. The phentermine is generally administered in...
2017/0151178 EASILY DOSABLE SOLID PREPARATION
It has been desired to develop a coating composition, which is used for an orally-administered preparation having an improved administering property, and/or an...
2017/0151177 LOXOPROFEN AND GAMMA-AMINOBUTIRIC ACID RECEPTOR AGONIST COMBINATIONS
This invention is a novel pharmaceutical composition comprising loxoprofen or a pharmaceutically acceptable salt thereof in combination with gamma-aminobutiric...
2017/0151176 GELATIN/PECTIN PARTICLES
Disclosed are particles comprising pectin and gelatin. The particles may be useful for preparing any of a variety products such as, for example, soft...
2017/0151175 INFANT NUTRITION WITH LIPID GLOBULES TO INCREASE ENERGY EXPENDITURE AND METABOLIC FLEXIBILITY LATER IN LIFE
The present invention relates to nutrition for infants and young children with particular lipid globules, resulting in programming the metabolism to an...
2017/0151174 MAGNETOENZYMATIC CARRIER SYSTEM FOR IMAGING AND TARGETED DELIVERY AND RELEASE OF ACTIVE AGENTS
The present invention relates to a composition comprising liposomes, wherein the liposomes preferably comprise phospholipids, magnetic nanoparticles, an...
2017/0151173 COMPOSITIONS AND METHODS FOR OTOLOGIC PROPHYLAXIS AND TREATMENT
A prophylactic method for preventing otitis media or Eustachian tube dysfunction, or reducing the severity of symptoms thereof, decreasing the risk of future...
2017/0151172 COMPOSITION FOR TOPICAL APPLICATION COMPRISING GLYCEROL AND TANNINS
A preparation for topical application comprising glycerol and plant tannins, wherein the plant tannins have the capacity to bind to glycerol so that the...
2017/0151171 COSMETIC COMPOSITION FOR ANTI-AGING
Provided is a cosmetic composition for anti-aging, which contains a spider web extract, a Pseudoalteromonas extract, a ginseng callus extract and a...
2017/0151170 Alcoholic extract of aerial parts of Solidago virgaurea subsp. alpestris, method of production thereof, and...
An alcoholic extract of aerial parts of Solidago virgaurea subsp. alpestris, the method of production thereof, a cosmetic or dermatological composition...
← Previous | 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 | Next →

File A Patent Application

  • Protect your idea -- Don't let someone else file first. Learn more.

  • 3 Easy Steps -- Complete Form, application Review, and File. See our process.

  • Attorney Review -- Have your application reviewed by a Patent Attorney. See what's included.